Showing results (101-110 of 291) with videos related to
Sort By:
Pageof 30
Haematologica|March 17, 2004
Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trialAxel Glasmacher, Hartmut Goldschmidt, Jörg Mezger, et al.Anti-Cancer Drugs|March 14, 2003
Weekly docetaxel in patients with pretreated metastatic breast cancer: a phase II trialU Mey, M Gorschlüter, C Ziske, et al.In Vivo (Athens, Greece)|October 25, 2011
Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma modelYoung Kim, Matthias Schmidt, Tomoyuki Endo, et al.Deutsche Medizinische Wochenschrift (1946)|October 1, 2014
[State of the art treatment of progressive or refractory multiple myeloma]I G H Schmidt-Wolf, C Straka, C Scheid, et al.European Journal of Medical Research|August 15, 2002
New aspects in the treatment of AIDS-related lymphomaI G H Schmidt-Wolf, J K Rockstroh, U Schlegel, et al.British Journal of Cancer|June 27, 2002
Generation of dendritic cell-based vaccines for cancer therapyG Reinhard, A Märten, S M Kiske, et al.Leukemia Research|March 6, 2012
In vivo efficacy of the diuretic agent ethacrynic acid against multiple myelomaYoung Kim, Sanna-Marie Gast, Tomoyuki Endo, et al.Cancer Investigation|January 7, 2021
Epigenetic Regulatory Enzymes: mutation Prevalence and Coexistence in CancersAmit Sharma, Hongde Liu, Martina C Herwig-Carl, et al.Leukemia Research|May 23, 2008
Endoscopy in patients with acute leukaemia after intensive chemotherapyMarcus Gorschlüter, Volker Schmitz, Ulrich Mey, et al.Anticancer Research|July 31, 2014
Targeting the Wnt/beta-catenin pathway in renal cell carcinomaSarah Annette Von Schulz-Hausmann, Leonard Christopher Schmeel, Frederic Carsten Schmeel, et al.Pageof 30